XWELL, Inc. (XWEL)
NASDAQ: XWEL · Real-Time Price · USD
0.8200
-0.0110 (-1.32%)
Nov 17, 2025, 1:04 PM EST - Market open
XWELL Market Cap
XWELL has a market cap or net worth of $4.72 million as of November 17, 2025. Its market cap has decreased by -50.92% in one year.
Market Cap
4.72M
Enterprise Value
10.00M
1-Year Change
-50.92%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since July 20, 2012, XWELL's market cap has decreased from $50.81M to $4.72M, a decrease of -90.71%. That is a compound annual growth rate of -16.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 4.78M | -39.72% |
| Dec 31, 2024 | 7.94M | 9.13% |
| Dec 29, 2023 | 7.27M | -75.92% |
| Dec 30, 2022 | 30.20M | -85.80% |
| Dec 31, 2021 | 212.76M | 90.15% |
| Dec 31, 2020 | 111.89M | 994.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |